首页> 外国专利> Use of Ganoderma lucidum fermented product for improving alcoholic liver disease, alcoholic fatty liver and diseases associated with inflammation

Use of Ganoderma lucidum fermented product for improving alcoholic liver disease, alcoholic fatty liver and diseases associated with inflammation

机译:灵芝发酵产品用于改善酒精性肝病,酒精性脂肪肝和炎症相关疾病的用途

摘要

OF THE DISCLOSURE Use of Ganoderma lucidum fermented product for improving alcoholic liver disease, alcoholic fatty liver and diseases associated 5 with inflammation. A Ganoderma lucidum fermented product is prepared in the form of a beverage or capsule, tablet or powder. Said fermented product can not only improve fatty liver, abnormal levels of liver biochemical markers, 10 abnormal serum cholesterol and bl ood glucose levels caused by reduced liver functions but also increase hepatic antioxidant concentrations and promote the activities of liver antioxidant enzymes after oral ingestion for a period of time. In addition to its inhibition effect on the inflammatory respons es in the liver, said fermented 15 product also has a significant inhi bition effect on the inflammatory responses in other tissues such as macrophages and intestinal cells. Fig. 1
机译:灵芝发酵产物用于改善酒精性肝病,酒精性脂肪肝和与炎症相关的疾病的用途5。灵芝发酵产品以饮料或胶囊,片剂或粉剂的形式制备。该发酵产品不仅可以改善脂肪肝,改善肝脏生化指标的异常水平,降低肝功能引起的10种异常的血清胆固醇和血糖水平升高,而且还可以增加肝脏抗氧化剂的浓度,并促进口服摄入肝的抗氧化酶的活性。一段的时间。除了对肝脏炎症反应的抑制作用外,所述发酵的15产品还对巨噬细胞和肠细胞等其他组织的炎症反应具有显着的抑制作用。图。1

著录项

  • 公开/公告号SG10201610865RA

    专利类型

  • 公开/公告日2018-07-30

    原文格式PDF

  • 申请/专利权人 SYNGEN BIOTECH CO. LTD.;

    申请/专利号SG10201610865R

  • 发明设计人 TSAI YU-LUN;CHEN WEI-JEN;HUNG CHIU-YA;

    申请日2016-12-27

  • 分类号

  • 国家 SG

  • 入库时间 2022-08-21 12:49:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号